Abstract |
The anti-emetic activity of oral and intravenously-administered BRL 46470 ( endo-N-(8-methyl-8-azabicyclo[3.2.1]oct-3yl)-2,3-dihydro-3,3- dimethyl- indole-1-carboxamide HCl) has been assessed in conscious ferrets. BRL 46470 (0.05-0.5 mg kg-1, p.o.) dose-dependently prevented emesis evoked over a 2 h period by total body X-irradiation. This anti-emetic activity occurred with oral or intravenously-administered BRL 46470 even when dosed 3-4 h before radiation. In conjunction with data obtained in other species, we conclude that BRL 46470 has a potent and long-lasting ability to antagonize actions that are mediated by the 5-HT3 receptor in-vivo.
|
Authors | J Bermudez, G J Sanger |
Journal | The Journal of pharmacy and pharmacology
(J Pharm Pharmacol)
Vol. 46
Issue 6
Pg. 520-1
(Jun 1994)
ISSN: 0022-3573 [Print] England |
PMID | 7932054
(Publication Type: Journal Article)
|
Chemical References |
- Antiemetics
- Bridged Bicyclo Compounds
- Bridged Bicyclo Compounds, Heterocyclic
- Indoles
- Serotonin Antagonists
- BRL 46470
|
Topics |
- Administration, Oral
- Animals
- Antiemetics
(pharmacology)
- Bridged Bicyclo Compounds
(pharmacology)
- Bridged Bicyclo Compounds, Heterocyclic
- Dose-Response Relationship, Drug
- Ferrets
- Indoles
(pharmacology)
- Injections, Intravenous
- Male
- Serotonin Antagonists
(pharmacology)
- Whole-Body Irradiation
|